Guardant Health
GH
#3559
Rank
โ‚น258.94 B
Marketcap
โ‚น2,105
Share price
-1.18%
Change (1 day)
-7.66%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น112.51 B

According to Guardant Health 's latest financial reports the company's total debt is โ‚น112.51 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น112.69 B-0.54%
2022-12-31โ‚น113.30 B10.68%
2021-12-31โ‚น102.37 B64.09%
2020-12-31โ‚น62.38 B2069.71%
2019-12-31โ‚น2.87 B
2018-12-31N/A-100%
2017-12-31โ‚น42.07 M-96.37%
2016-12-31โ‚น1.15 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚น36.71 B-67.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น74.73 B-33.57%๐Ÿ‡บ๐Ÿ‡ธ USA